AKR1A1 Variant Associated With Schizophrenia Causes Exon Skipping, Leading to Loss of Enzymatic Activity
Kyoka Iino(Tokyo Metropolitan Matsuzawa Hospital), Makoto Arai(Tokyo Metropolitan Institute of Medical Science), Atsushi Imai(Tokyo Metropolitan Matsuzawa Hospital), Masanari Itokawa(Fujita Health University), Shinsuke Washizuka(Shinshu University), Norio Ozaki(Nagoya University), Shunya Takizawa(Tokai University), Kazuhiro Suzuki(National Institute of Health Sciences), Mitsuhiro Miyashita(Tokyo Metropolitan Institute of Medical Science), Ryota Hashimoto(National Center of Neurology and Psychiatry), Kazuhiro Niizato(Tokyo Metropolitan Matsuzawa Hospital), Eiichiro Nagata(Tokai University), Itaru Kushima(Nagoya University), Shinsuke Koike, Yukihiro Nagase(Takatsuki General Hospital), Riko Agarie(Tokyo Metropolitan Matsuzawa Hospital), Tempei Ikegame(The University of Tokyo), Yasue Horiuchi(National Taiwan University), Kazuya Toriumi(Tokyo Metropolitan Institute of Medical Science), Toshio Miyata(Waseda University), Seiichiro Jinde(The University of Tokyo), Kenichi Oshima(Tokyo Metropolitan Matsuzawa Hospital), Kiyoto Kasai(The University of Tokyo)
Cited by 7
Related Papers
Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group
|Molecular Psychiatry|2017|733
Improving polygenic prediction in ancestrally diverse populations
|Nature Genetics|2022|714
Protein-bound acrolein: Potential markers for oxidative stress
|Proceedings of the National Academy of Sciences|1998|631
Alterations in nonenzymatic biochemistry in uremia: Origin and significance of “carbonyl stress” in long-term uremic complications
|Kidney International|1999|516
Middle and Inferior Temporal Gyrus Gray Matter Volume Abnormalities in Chronic Schizophrenia: An MRI Study
|American Journal of Psychiatry|2004|514